Halozyme Therapeutics (HALO) Operating Income (2010 - 2026)
Halozyme Therapeutics' Operating Income was $287.65 million in Q2 2026, up 42.1% from $202.44 million a year earlier and up 55.9% from the prior quarter.
Powered by 
Analysis
Halozyme Therapeutics (HALO) Operating Income (2010 - 2026) Analysis & Trends
On a trailing twelve-month basis, Halozyme Therapeutics' Operating Income was $597.2 million through Jun 30, 2026, down 12.5% year-over-year; for FY2025, it was $469.01 million, down 15.0% from FY2024.
- Operating Income shows a five-year compound annual growth rate of 26.6% (FY2020 to FY2025).
- In earlier years, Operating Income was $551.48 million in FY2024 (+63.4%), $337.57 million in FY2023 (+26.2%), $267.53 million in FY2022 (-3.0%) and $275.9 million in FY2021 (+91.3%).
- The Q2 2026 figure marks the highest quarterly Operating Income in data going back to Q2 2010.
- The best year-over-year quarter for Operating Income over five years was Q2 2023 (growth of 177.3%); the worst was Q2 2022 (a decline of 63.4%).
- Per Business Quant data, HALO's Operating Income in the three quarters before Q2 2026 was $184.52 million (Q1 2026), -$92.89 million (Q4 2025) and $217.92 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 7.14 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 6.43 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | -584.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 4.75 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 3.16 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 3.51 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -10.39 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.27 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 1.25 Bn |
| 10 | Halozyme Therapeutics | 12.59 Bn | 11.20 Bn | 401.83 Mn | 287.65 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 287.65 Mn |
| Mar 31, 2026 | 184.52 Mn |
| Dec 31, 2025 | -92.89 Mn |
| Sep 30, 2025 | 217.92 Mn |
| Jun 30, 2025 | 202.44 Mn |
| Mar 31, 2025 | 141.54 Mn |
| Dec 31, 2024 | 175.50 Mn |
| Sep 30, 2024 | 163.20 Mn |
| Jun 30, 2024 | 117.24 Mn |
| Mar 31, 2024 | 95.54 Mn |
| Dec 31, 2023 | 101.04 Mn |
| Sep 30, 2023 | 88.28 Mn |
| Jun 30, 2023 | 94.46 Mn |
| Mar 31, 2023 | 53.80 Mn |
| Dec 31, 2022 | 74.51 Mn |
| Sep 30, 2022 | 83.29 Mn |
| Jun 30, 2022 | 34.06 Mn |
| Mar 31, 2022 | 75.67 Mn |
| Dec 31, 2021 | 56.53 Mn |
| Sep 30, 2021 | 75.59 Mn |
API Access
Halozyme Therapeutics Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-income&ticker=HALO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-income", "ticker": "HALO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-income&ticker=HALO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();